Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Sangamo Therapeutics (NQ: SGMO )

9.890 USD -0.620 (-5.90%)
Official Closing Price Updated: 7:54 PM EDT, Sep 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Sangamo Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
Stocks Flashing Renewed Technical Strength: Sangamo Therapeutics
Sangamo Therapeutics sees its Relative Strength Rating enter the 80-plus level. 
From Investor's Business Daily
Sangamo Therapeutics Scores Relative Strength Rating Upgrade; Hits Key Threshold
A Relative Strength Rating upgrade for Sangamo Therapeutics shows improving technical performance. 
From Investor's Business Daily
January 2023 Options Now Available For Sangamo Therapeutics (SGMO)
Investors in Sangamo Therapeutics Inc (SGMO) saw new options begin trading today, for the January 2023 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is... 
Tags Stocks
From Market News Video
Sangamo Therapeutics Appoints Kenneth Hillan to Its Board of Directors
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of Dr. Kenneth Hillan, an accomplished biotechnology executive, to the Company's Board of... 
From Business Wire News Releases
Sangamo Therapeutics Getting Closer To Key Technical Benchmark
A Relative Strength Rating upgrade for Sangamo Therapeutics shows improving technical performance. Will it continue? 
From Investor's Business Daily
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences: 
From Business Wire News Releases
First Week of October 16th Options Trading For Sangamo Therapeutics (SGMO)
Investors in Sangamo Therapeutics Inc (SGMO) saw new options become available this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: CureVac Close To Coronavirus Vaccine Deal With EU, Entera Bio's Positive Readout, Patent Protection For Co-Diagnostics
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) 10X Genomics Inc (NASDAQ: TXG) ALX Oncology Holdings Inc ... 
Tags REPH MRTX Penny Stocks
From Benzinga
Stocks With Rising Relative Price Strength: Sangamo Therapeutics
A Relative Strength Rating upgrade for Sangamo Therapeutics shows improving technical performance. 
From Investor's Business Daily
Stocks That Hit 52-Week Highs On Wednesday
This morning 90 companies reached new 52-week highs. Interesting Highlights: Apple (NASDAQ: AAPL) was the biggest firm by ... 
Tags OSTK GRWG TRIL
From Benzinga
Sangamo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Conference
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present at the 2020 Wedbush PacGrow Healthcare Conference on August 12,... 
From Business Wire News Releases
The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 6) ADiTx Therapeutics Inc (NASDAQ: ADTX) (announced introduction ... 
Tags ADTX Health Care CHRS
From Benzinga
Noteworthy Thursday Option Activity: OPY, DISH, SGMO
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Oppenheimer Holdings Inc Class A (D (OPY), where a total of 510 contracts have traded so... 
Tags Stocks
From Market News Video
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 227 companies set new 52-week highs. Interesting Highlights: Apple (NASDAQ: AAPL) was the ... 
Tags VIPS ACMR HZO
From Benzinga
Sangamo Therapeutics Inc (SGMO) Q2 2020 Earnings Call Transcript
SGMO earnings call for the period ending June 30, 2020. 
Tags Market News SGMO
From Motley Fool
Sangamo Therapeutics Reports Business Highlights and Second Quarter 2020 Financial Results
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported second quarter 2020 financial results and recent business highlights. 
From Business Wire News Releases
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of ... 
Tags TRVN RMD ALXO
From Benzinga
Earnings Scheduled For August 5, 2020
Companies Reporting Before The Bell • AmerisourceBergen Inc. (NYSE:ABC) is expected to report quarterly earnings at $1.56 per ... 
Tags ROKU TGB SPT
From Benzinga
Excision BioTherapeutics Appoints Veteran Genome Editing Expert TJ Cradick, PhD as Chief Scientific Officer
Cradick will lead Excision’s development programs from research to clinical trials 
From GlobeNewswire News Releases
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical ... 
Tags KPTI ALNY NKTX
From Benzinga
88 Biggest Movers From Yesterday
Gainers Precipio, Inc. (NASDAQ: PRPO) shares jumped 469.1% to close at $7.00 on Thursday after the company reported the commercial ... 
Tags Trading Ideas ADMA AXL
From Benzinga
Stock Upgrades: Sangamo Therapeutics Shows Rising Relative Strength
Sangamo Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 74 to 87. 
From Investor's Business Daily
75 Stocks Moving In Thursday's Mid-Day Session
Gainers Taoping Inc. (NASDAQ: TAOP) shares jumped 408.5% to $10.37 as the company disclosed that it has upgraded its Taoping Smart ... 
Tags CNSL LMNL CLRB
From Benzinga
Sangamo Announces Global Collaboration With Novartis to Develop Genomic Medicines for Autism and Other Neurodevelopmental Disorders
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that it has executed a global licensing collaboration agreement with Novartis to develop and commercialize gene... 
From Business Wire News Releases
Sangamo Therapeutics Announces Second Quarter 2020 Conference Call and Webcast
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has scheduled the release of its second quarter 2020 financial results after the market closes on... 
From Business Wire News Releases
Here's Why Biogen Just Blew Its Q2 Earnings Out of the Water
It wasn't because of revenue growth. 
Tags RHHB/Y BIIB Market News
From Motley Fool
Biogen (BIIB) Beats on Q2 Earnings, Raises EPS View, Stock Up
Biogen reported second-quarter 2020 earnings per share of $10.26. 
Tags Stocks / Equities
From Blogs - TalkMarkets
3 Top Biotech Stocks to Watch in July
These three stocks are positioned for growth -- but investors must tread carefully in the short term. 
Tags EDIT Market News ABBV
From Motley Fool
Stock Upgrades: Sangamo Therapeutics Shows Rising Relative Strength
Sangamo Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 86. 
From Investor's Business Daily
Implied VB Analyst Target Price: $160
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.